Nicholas Bellamy
#119,778
Most Influential Person Now
Nicholas Bellamy's AcademicInfluence.com Rankings
Nicholas Bellamymathematics Degrees
Mathematics
#5814
World Rank
#8152
Historical Rank
Statistics
#459
World Rank
#532
Historical Rank
Measure Theory
#951
World Rank
#1238
Historical Rank
Download Badge
Mathematics
Nicholas Bellamy's Degrees
- PhD Biostatistics University of California, Berkeley
- Masters Statistics Stanford University
Why Is Nicholas Bellamy Influential?
(Suggest an Edit or Addition)Nicholas Bellamy's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. (1988) (7236)
- Core outcome measures for chronic pain clinical trials: IMMPACT recommendations (2003) (3437)
- Core outcome domains for chronic pain clinical trials: IMMPACT recommendations (2003) (1059)
- Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement (2004) (858)
- Viscosupplementation for the treatment of osteoarthritis of the knee. (2006) (821)
- Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. (1997) (730)
- OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. (2004) (716)
- Validation study of WOMAC : a health status instrument for measuring clinically-important patient-relevant outcomes following total hip or knee arthroplasty in osteoarthritis (1988) (650)
- Design and conduct of clinical trials in patients with osteoarthritis : Recommendations from a task force of the Osteoarthritic Research Society (1996) (508)
- Intraarticular corticosteroid for treatment of osteoarthritis of the knee. (2005) (500)
- Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. (2000) (460)
- Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state (2004) (441)
- Responsiveness of the short form-36, disability of the arm, shoulder, and hand questionnaire, patient-rated wrist evaluation, and physical impairment measurements in evaluating recovery after a distal radius fracture. (2000) (387)
- A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. (2001) (379)
- The burden of musculoskeletal conditions at the start of the new millennium (2003) (362)
- Connective tissue diseases. (1973) (359)
- Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations (2010) (323)
- Pain assessment in osteoarthritis: experience with the WOMAC osteoarthritis index. (1989) (307)
- Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis. (1999) (306)
- Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study (2012) (292)
- WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. (2002) (286)
- Intraarticular corticosteroid for treatment of osteoarthritis of the knee. (2006) (280)
- Dimensionality and clinical importance of pain and disability in hand osteoarthritis: Development of the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index. (2002) (262)
- Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. (2003) (250)
- Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. (1997) (249)
- Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial (2012) (248)
- Clinimetric properties of the AUSCAN Osteoarthritis Hand Index: an evaluation of reliability, validity and responsiveness. (2002) (234)
- Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations (2012) (229)
- A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. (2002) (216)
- The WOMAC Knee and Hip Osteoarthritis Indices: development, validation, globalization and influence on the development of the AUSCAN Hand Osteoarthritis Indices. (2005) (209)
- Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations (2008) (197)
- A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee (1986) (197)
- Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. (1996) (196)
- Guidelines for testing slow acting drugs in osteoarthritis. (1994) (196)
- Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. (2000) (190)
- Reliability of the knee examination in osteoarthritis: effect of standardization. (2004) (188)
- Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. (2000) (179)
- Validation study of a computerized version of the Western Ontario and McMaster Universities VA3.0 Osteoarthritis Index. (1997) (174)
- Alcohol ignition interlock programmes for reducing drink driving recidivism. (2004) (169)
- Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index. (1992) (167)
- Outcome measurement in osteoarthritis clinical trials. (1995) (156)
- Evidence-based Management of Acute Musculoskeletal Pain (2003) (155)
- Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise. (1992) (146)
- A cross-sectional study of the association between Heberden's nodes, radiographic osteoarthritis of the hands, grip strength, disability and pain. (2001) (146)
- Musculoskeletal Clinical Metrology (1993) (141)
- Osteoarthritis clinical trials: candidate variables and clinimetric properties. (1997) (140)
- A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip (2013) (132)
- Comparison of the responsiveness and relative effect size of the western Ontario and McMaster Universities Osteoarthritis Index and the short-form Medical Outcomes Study Survey in a randomized, clinical trial of osteoarthritis patients. (1999) (122)
- Rhythmic variations in pain perception in osteoarthritis of the knee. (1990) (119)
- Clinical evaluation of the WOMAC 3.0 OA Index in numeric rating scale format using a computerized touch screen version. (2002) (118)
- An experiment in reducing interobserver variability of the examination for joint tenderness. (1988) (101)
- What do we know about the sacroiliac joint? (1983) (101)
- A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis Index. (1994) (100)
- Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. (1999) (95)
- Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. (2007) (92)
- Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis (2002) (91)
- A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial. (2017) (90)
- A comparative study of telephone versus onsite completion of the WOMAC 3.0 osteoarthritis index. (2002) (88)
- Progression of hand osteoarthritis over 2 years: a clinical and radiological follow-up study (2008) (87)
- Validation and patient acceptance of a computer touch screen version of the WOMAC 3.1 osteoarthritis index (2004) (82)
- Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. (1991) (82)
- Osteoarthritis Index delivered by mobile phone (m-WOMAC) is valid, reliable, and responsive. (2011) (80)
- Variability of skin scores and clinical measurements in scleroderma. (1995) (78)
- Development of Multinational Definitions of Minimal Clinically Important Improvement and Patient Acceptable Symptomatic State in Osteoarthritis (2015) (76)
- A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results. (2002) (71)
- Minimal clinically important difference module: summary, recommendations, and research agenda. (2001) (71)
- Population-based normative values for the Western Ontario and McMaster (WOMAC) Osteoarthritis Index: part I. (2011) (71)
- Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. (1999) (69)
- Clinimetric concepts in outcome assessment: the OMERACT filter. (1999) (66)
- The Detection of Psychiatric Morbidity and Associated Factors in Patients with Rheumatoid Arthritis * (1987) (65)
- Comparative study of self-rating pain scales in osteoarthritis patients. (1999) (63)
- Rheumatoid arthritis in twins: a study of aetiopathogenesis based on the Australian Twin Registry. (1992) (61)
- A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee. (2007) (60)
- Validity and reliability of the Persian versions of WOMAC Osteoarthritis Index and Lequesne Algofunctional Index (2011) (59)
- Reliability of the hip examination in osteoarthritis: effect of standardization. (2008) (58)
- Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis (2004) (58)
- Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. (2005) (57)
- Towards a definition of "difference" in osteoarthritis. (2001) (55)
- Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs. (1987) (54)
- Quantitative rheumatology: a survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada. (1998) (54)
- Health outcomes of adults 3 months after injury. (2007) (53)
- Erratum: Guidelines for testing slow acting drugs in osteoarthritis (Journal of Rheumatology (1994) (Suppl 41) 21: (65-71)) (1994) (50)
- Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. (1991) (49)
- Osteoporosis in rheumatoid arthritis. A monozygotic co-twin control study. (1995) (48)
- Aspects of diurnal rhythmicity in pain, stiffness, and fatigue in patients with fibromyalgia. (2004) (48)
- Performance of the Norwegian version of AUSCAN--a disease-specific measure of hand osteoarthritis. (2005) (47)
- Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel (2003) (46)
- Using patients’ and rheumatologists’ opinions to specify a short form of the WOMAC function subscale (2004) (46)
- A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario. (1988) (46)
- A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee. (1993) (45)
- Prior score availability: observations using the WOMAC osteoarthritis index. (1991) (44)
- Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials. (1992) (44)
- Relationship between severity and clinical importance of symptoms in osteoarthritis (1991) (44)
- Epidemiology of traumatic epidural hematoma in young age. (2011) (42)
- Methods of assessment used in ankylosing spondylitis clinical trials: a review. (1991) (42)
- Outcome measurement in scleroderma clinical trials. (1993) (42)
- Perceptual variation in categorizing individuals according to American College of Rheumatology classification criteria for hand, knee, and hip osteoarthritis (OA): observations based on an Australian Twin Registry study of OA. (1999) (42)
- Judging "current disease activity" in rheumatoid arthritis--an international comparison. (1983) (41)
- Long‐term outcomes of seriously injured children: A study using the Child Health Questionnaire (2005) (41)
- Validation of the Chinese Western Ontario and McMaster Universities Osteoarthritis Index in Patients From Mainland China With Osteoarthritis of the Knee (2015) (39)
- A Canadian survey on the management of corticosteroid induced osteoporosis by rheumatologists. (2000) (39)
- Comparative study of self-rating pain scales in rheumatoid arthritis patients. (1999) (39)
- Gold therapy in the elderly rheumatoid arthritis patient. (1983) (38)
- Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial (2012) (37)
- The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis (2016) (37)
- A survey of outcome measurement procedures in routine rheumatology outpatient practice in Australia. (1999) (36)
- The lack of associations between rheumatoid arthritis and both nulliparity and infertility. (1999) (35)
- Viscosupplementation for the treatment of osteoarthritis of the knee. (2006) (35)
- A comparison of injuries to moped/scooter and motorcycle riders in Queensland, Australia. (2013) (35)
- Continuing medical education‐driven skills acquisition and impact on improved patient outcomes in family practice setting (2000) (34)
- Outcome measurement in osteoarthritis clinical trials: The case for standardisation (1984) (33)
- A survey of current prescribing practices of anti‐inflammatory and urate‐lowering drugs in gouty arthritis in New South Wales and Queensland (1989) (33)
- Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group (2003) (33)
- Science of assessment (2005) (32)
- Excitatory amino acid inhibitors for traumatic brain injury. (2003) (32)
- The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI. (2005) (31)
- The validity and heritability of self-report osteoarthritis in an Australian older twin sample. (2002) (31)
- Low dose cyclosporine in rheumatoid arthritis: a pilot study. (1987) (31)
- Signal measurement strategies: are they feasible and do they offer any advantage in outcome measurement in osteoarthritis? (1990) (30)
- Controlled, double-blind, randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis. (1985) (30)
- Osteoarthritis of the hands, hips and knees in an Australian twin sample--evidence of association with the aggrecan VNTR polymorphism. (2003) (30)
- Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. (1991) (29)
- Necrotizing mesenteric vasculitis after longstanding cutaneous polyarteritis nodosa. (1992) (29)
- Delineating Communication Impairments Associated With Mild Traumatic Brain Injury: A Case Report (2007) (29)
- Population-based normative values for the Western Ontario and McMaster (WOMAC®) osteoarthritis index and the Australian/Canadian (AUSCAN) hand osteoarthritis index functional subscales (2010) (28)
- Prognosis in the Rheumatic Diseases (2012) (28)
- Inclusion of 'minor' trauma cases provides a better estimate of the total burden of injury: Queensland Trauma Registry provides a unique perspective. (2014) (27)
- Instruments to assess osteoarthritis--current status and future needs. (1995) (27)
- Validation of a prediction model to estimate health utilities index Mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the hip. (2008) (26)
- Comparative validation of the WOMAC osteoarthritis and Lequesne algofunctional indices in Greek patients with hip or knee osteoarthritis (2014) (26)
- A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis. (1995) (26)
- Perception--a problem in the grading of sacro-iliac joint radiographs. (1984) (26)
- Perceptual variation in grading hand, hip and knee radiographs: observations based on an Australian Twin Registry study of osteoarthritis (1999) (25)
- Conference summary. Workshop on chronic pain, pain control, and patient outcomes in rheumatoid arthritis and osteoarthritis (1996) (25)
- A survey of current prescribing practices of antiinflammatory and urate-lowering drugs in gouty arthritis. (1991) (25)
- Clinical trials design: structure modifying agents for osteoarthritis. Future guidelines: areas for development. (1999) (24)
- Responsiveness of the electronic touch screen WOMAC 3.1 OA Index in a short term clinical trial with rofecoxib. (2004) (24)
- Current practice in antimalarial drug prescribing in rheumatoid arthritis. (1986) (23)
- Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis. (2014) (22)
- Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. (1991) (22)
- Double-blind randomized controlled trial of isoxicam vs piroxicam in elderly patients with osteoarthritis of the hip and knee. (1986) (22)
- The epidemiology of horse-related injuries for different horse exposures, activities, and age groups in Queensland, Australia (2014) (21)
- Outcome measurement in Australian rehabilitation environments. (2005) (21)
- Principles of outcome assessment (2003) (20)
- Health status instruments / utilities. (1995) (19)
- BLISS index for analyzing knee osteoarthritis trials data. (2007) (19)
- International estimation of Minimally Clinically Important Improvement (MCII75): The Reflect Study (2007) (17)
- Critical review of clinical assessment techniques for rheumatoid arthritis trials: new developments. (1989) (17)
- Double-blind randomized controlled trial and six-year open follow-up of yttrium-90 radiosynovectomy versus triamcinolone hexacetonide in persistent rheumatoid knee synovitis (1992) (17)
- The University of Queensland study of physical and psychological outcomes for claimants with minor and moderate injuries following a road traffic crash (UQ SuPPORT): design and methods (2014) (16)
- Electronic data capture using the Womac® NRS 3.1 Index (m-Womac®): a pilot study of repeated independent remote data capture in OA (2010) (15)
- Clinimetric properties of WOMAC index in Greek knee osteoarthritis patients: comparisons with both self-reported and physical performance measures (2014) (15)
- Tackling the burden of injury in Australasia: developing a binational trauma registry (2006) (15)
- Electronic Data Capture (EDC) using cellular technology: Implications for clinical trials and practice, and preliminary experience with the m-Womac® Index in hip and knee OA patients (2009) (14)
- Characteristics and outcomes of injury patients in an Aboriginal and Torres Strait Islander population--Queensland Trauma Registry, Australia. (2010) (14)
- Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials. (1995) (14)
- Population-based normative values for the Australian/Canadian (AUSCAN) Hand Osteoarthritis Index: part 2. (2011) (13)
- Relapsing polychondritis in pregnancy. (1990) (13)
- Variance in NSAID studies: contribution of patient variance. (1985) (13)
- Cross-cultural adaptation, validation, and responsiveness of the Korean version of the AUSCAN Osteoarthritis Index (2011) (12)
- Workshop on chronic pain, pain control, and patient outcomes in rheumatoid arthritis and osteoarthritis. (1996) (12)
- Structure modifying effects of Strontium Ranelate in knee osteoarthritis (2012) (12)
- Osteoarthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. (1992) (12)
- Improvement in condition-specific and generic quality of life outcomes in patients with knee osteoarthritis following single-injection Synvisc: results from the LOBRAS study (2017) (11)
- International estimation of Patient Acceptable Symptom Severity (PASS75): The Reflect Study (2007) (11)
- Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. (1991) (11)
- Prevalence of patient with low intensity pain symptom severity states during treatment with Rofecoxib and Ibuprofen for osteoarthritis (2004) (11)
- Immunoregulation in rheumatoid arthritis: evaluation of T lymphocyte function in the control of polyclonal immunoglobulin synthesis in vitro. (1983) (11)
- Osteoarthritis Measurement in Routine Rheumatology Outpatient Practice (OMIRROP) in Australia: A Survey of Practice Style, Instrument Use, Responder Criteria, and State-Attainment Criteria (2009) (11)
- Health Status Instruments and Functional Indices (1993) (10)
- BLISS index using WOMAC index detects between-group differences at low-intensity symptom states in osteoarthritis. (2010) (10)
- Statistical reappraisal of the clinical significance of nail beading in rheumatoid arthritis. (1985) (10)
- A multicentre randomised, 1-year comparative effectiveness, parallel-group trial protocol of a physical therapy approach compared to corticosteroid injections (2016) (10)
- The clinical evaluation of osteoarthritis in the elderly. (1986) (9)
- Clinical evaluation in the rheumatic diseases (2000) (9)
- Intra-articular treatment of osteoarthritis of the knee. Corticosteroid versus hyaluronan/hylan: Cochrane Review (2005) (9)
- Double-blind randomized controlled trial of flurbiprofen-SR (ANSAID-SR) and diclofenac sodium-SR (Voltaren-SR) in the treatment of osteoarthritis. (1992) (9)
- Prognosis in rheumatoid arthritis. (1991) (9)
- Acute neck pain (2004) (9)
- Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials. (1991) (9)
- Clinical evaluation of two strategies for improving patient recall of prior drug therapy. (1984) (8)
- Hyaluronic acid and knee osteoarthritis. (2006) (8)
- Principles of clinical outcome assessment (2011) (8)
- Development, linguistic and clinimetric validation of the WOMAC® VA3.01 Bangla for Bangladesh Index (2015) (8)
- Evaluation of clinically relevant changes and states in symptomatic outcome variables in osteoarthritis of the lower limbs (2003) (8)
- A Canadian survey of current methotrexate prescribing practices in rheumatoid arthritis. (1994) (8)
- Osteoarthritis research society international hand OA task force: design and conduct of clinical trials on osteoarthritis (OA) of the hand (2004) (7)
- Management of acute musculoskeletal pain (2005) (7)
- Incorporation of environmental factors into outcomes research (2003) (7)
- Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs. (1991) (7)
- Health Outcome Assessment (2000) (7)
- Outcome measures in osteoarthritis (2002) (7)
- Fibromyalgia antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent outcome measures (1997) (7)
- A comparative study of the relative efficiency of the WOMAC, AIMS and HAQ instruments in evaluating the outcome of total KNEE arthroplasty (1995) (7)
- Osteoarthritis antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent dependent outcome measures (1997) (7)
- Acute shoulder pain (2004) (6)
- Ankylosing spondylitis antirheumatic drug trials: Effects of a standardized instructional viddeotape on the reliability of observer-dependent outcome measures (1997) (6)
- A study of the time frame dependency of responses to the WOMAC osteoarthritis index (1993) (6)
- Methods of clinical assessment of anti-rheumatic drugs. (1988) (6)
- Standardised Procedures for Outcome Measurement and Parameters for Calculating Sample Size for Antirheumatic Drug Studies (1993) (6)
- Perceptual variation in categorizing individual peripheral joints for the presence or absence of osteoarthritis using a standard homunculus: observations based on an australian twin registry study of osteoarthritis (1999) (6)
- Response and state-attainment criteria in hand OA: analysis from a placebo-controlled clinical trial of CRX-102, a novel synergistic combination therapy (2007) (6)
- Treatment considerations in the elderly rheumatic patient. (1988) (5)
- An Australian survey of current prescribing practices of methotrexate in rheumatoid arthritis. (1994) (5)
- Estimation of observer reliability and sample size calculation parameters for outcome measures in fibromyalgia clinical trials (1994) (5)
- WOMAC 20, 50, 70 response levels in patients treated with Rofecoxib for osteoarthritis (2004) (5)
- Clinical evaluation of a new controlled-release formulation of naproxen in osteoarthritis and rheumatoid arthritis (1988) (5)
- Assessment of antirheumatic activity in man. (1990) (5)
- Comparison of transformed visual analogue and native numerical rating scaled patient responses to the WOMAC® Index (2011) (5)
- Rheumatoid arthritis antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent outcome measures (1997) (5)
- Weighting and Aggregation (1993) (5)
- Guidelines for testing slow acting drugs in arthritis--addendum. (1995) (5)
- Community-based Normative Values for disability derived from WOMAC and AUSCAN NRS 3.1 Indices - Oral (2007) (4)
- Outcome measures in clinical trials (2002) (4)
- An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for fibromyalgia (2008) (4)
- Efficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: a double-blind comparison with standard naproxen followed by an open-label trial. (1992) (4)
- Update 2006: Cochrane review of viscosupplementation for the treatment of osteoarthritis of the knee (2006) (4)
- An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for osteoarthritis (2008) (4)
- A methodological appraisal of the impact of different classification procedures used in three different phases of the australian rheumatoid arthritis twin survey (1998) (4)
- An evaluation of the convergence between three different methods of response status assignment (RSA) based on the WOMAC Osteoarthritis Index (2002) (4)
- Interpreting clinical trials of antirheumatic drug therapy. (1986) (4)
- Impact of OARSI/OMERACT recommendations for outcome measurement on clinical practice: A 5 year reassessment (2002) (3)
- Journal of Rheumatology. ILAR 2001. Abstracts of the 20th Congress of the International League of Associations for Rheumatology (2001) (3)
- Western Ontario and McMaster Universities Osteoarthritis Index (2020) (3)
- A comparative analysis of two dosing strategies of flurbiprofen in rheumatoid arthritis: an application of sequential trial design. (1988) (3)
- Arthritis in pregnancy (1991) (3)
- Mechanical and Electromechanical Devices (1993) (2)
- The Placebo Response: Clinical Efficacy and Toxicity (1997) (2)
- An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for ankylosing spondylitis (2008) (2)
- A Selective Critical but Constructive Desktop Appraisal of the American Medical Association Guides to the Evaluation of Permanent Impairment (AMA 6) (2009) (2)
- The Evolution of Assessment Techniques (1993) (2)
- OMERACT-OARSI Initiative: OARSI set of responder criteria for osteoarthritis (OA) clinical trials revisited (2002) (2)
- Clinical trials: proposal for an international coding system (ICS). (1984) (2)
- NSAIDs: Clinical efficacy and toxicity (1991) (2)
- Health related quality of life and the burden of disease in Australian rheumatology practice (2003) (2)
- PARIS SECTOGRAM: A METHOD FOR WEIGHTING AND AGGREGATING THE AUSCAN OSTEOARTHRITIS HAND INDEX (1998) (2)
- European Congress on Osteoporosis & Osteoarthritis (IOF-ECCEO12) (2012) (2)
- The Validity and Heritability of Self-Report Osteoarthritis in an Australian Older Twin Sample (2002) (2)
- A prospective randomized health outcomes trial of hylan G-F 20 in the treatment of patients with knee osteoarthritis (2000) (2)
- Evaluation of the patient. B. Health status questionnaires (2002) (2)
- Evaluation of factors influencing the item content of the short-form WOMAC VA3.1 (SF-WOMAC VA3.1) Osteoarthritis Index (2002) (2)
- Influence of methodology on conflicting results of metaanalyses in systematic reviews: Implications for decision-making in osteoarthritis (2006) (1)
- Clinical assessment in osteoarthritis (2003) (1)
- Do rheumatic patients comply? (1984) (1)
- A RANDOMISED DOUBLE-BLIND PLACE-BOCONTROLLED CROSSOVER TRIAL OF ADALIMUMAB FOR EROSIVE HAND OSTEOARTHRITIS: THE HUMOR TRIAL (2017) (1)
- Clinical outcome measurement (2002) (1)
- Open-label tolerability study of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis. (1992) (1)
- Symptom free response using the WOMAC pain score in patients treated with hylan G-F 20 for knee osteoarthritis (2003) (1)
- International Journal of Disability Management Research (2008) (1)
- Glucosamine therapy: does it work? (2001) (1)
- Treating musculoskeletal disease with NSAIDs. Practitioner's guide. (1996) (1)
- AB0962 Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled international trial (2013) (1)
- Strontium Ranelate in Knee Osteoarthritis Trial (SEKOIA): A Structural and Symptomatic Efficacy. (2012) (1)
- Clinical trial methodology in rheumatoid arthritis: azapropazone studies (1989) (1)
- How important is flare in the design of NSAID Trials in the treatment of osteoarthritis (OA) (2000) (1)
- PAR9 A MODEL TO ESTIMATE HEALTH UTILITIES INDEX MARK 3 UTILITY SCORES FROM WOMAC INDEX SCORES IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE (2005) (1)
- Queensland Trauma Plan Project 2001 - 2005 (2005) (1)
- Response to Dr C. Daniel Mullins’ letter [re: Osteoarthritis and Cartilage, 2002; 10:518–27] (2003) (1)
- Acute thoracic spinal pain (2004) (1)
- Observations on alternate propositions for a short-form WOMAC osteoarthritis index (SF-WOMAC) (2003) (1)
- 239 PROGRESSION OF HAND OSTEOARTHRITIS OVER TWO YEARS: A CLINICAL AND RADIOLOGICAL FOLLOW-UP STUDY (2007) (1)
- In vitro studies on immunoregulation with special reference to rheumatoid arthritis (1981) (1)
- Effects of aspirin, naloxone and placebo (1987) (1)
- Corticosteroids, osteoporosis and the Australian rheumatologist (1999) (1)
- Comparison of the responsiveness of the physical function subscale of the AUSCAN 3.0 OA hand index and the functional index for hand OA (FIHOA) (2002) (1)
- A Cochrane Review of viscosupplementation: Hylan G-F 20 versus placebo (2005) (1)
- An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for rheumatoid arthritis (2008) (1)
- An evaluation of the safety and effectiveness of repeat courses of hylan G-F 20 for treating patients with knee osteoarthritis (2002) (1)
- Colour Atlas of Clinical Rheumatology (1985) (1)
- Dr. Douglas Taylor and half a century of musculoskeletal Kelvinism (1988) (1)
- Reliability and standardization of the hip examination in osteoarthritis (2008) (1)
- The effectiveness, cost-effectiveness and cost-utility of hylan G-F 20 in osteoarthritis of the knee: Economic results (2000) (1)
- Incidence and outcomes of traumatic subdural haematoma across different age groups (2010) (1)
- Observations on Module 4 (Patient Global Assessment) of the Osteoarthritis Modular Measurement System (02MSTM) (2011) (1)
- WOMAC 20, 50, 70 response levels in patients treated with hylan G-F 20 for knee osteoarthritis (2003) (1)
- Preliminary definition of clinical response for osteoarthritis (OA) trials in knee and hip. A preliminary report of the Osteoarthritis Research Society International (OARSI). Standing Committee for Clinical Trials Response Criteria Initiative (2000) (1)
- Excitatory amino acid inhibitors for traumatic brain injury (Protocol for a Cochrane Review) (2003) (1)
- Evaluation of an ELISA system for determination of class-specific antibodies to native and denatured DNA in man (1986) (0)
- The incorporation of environmental variables in outcome measurement: A current challenge and future frontier being explored by CONROD (2002) (0)
- Responder criteria and state-attainment criteria in OA (2006) (0)
- Design of clinical trials for evaluation of structure modifying drugs and new agents for symptomatic treatment of osteoarthritis (2003) (0)
- Health status assessment in reabilitation (2002) (0)
- AB0868 A Preliminary Exploration of the Effect of Two Different Acceptability Statement Strategies on Estimates of Patient Acceptable Symptomatic State (Pass) in Osteoarthritis (OA) (2015) (0)
- 255 OSTEOARTHRITIS MEASUREMENT IN ROUTINE RHEUMATOLOGY OUTPATIENT PRACTICE (OMIRROP) IN AUSTRALIA: A SURVEY OF PRACTICE STYLE, INSTRUMENT USE, RESPONDER CRITERIA AND STATE-ATTAINMENT CRITERIA (2008) (0)
- The International Forum on Disability Management (IFDM) (2007) (0)
- An Evaluation of the Age, Gender and Item Specificity of Difficulty in Physical Functioning (2014) (0)
- Can study selection, variable management and time period influence observed effect sizes in systematic reviews of hyaluronan/hylan products? (2005) (0)
- International Journal of Disability Management Research (IJDMR) in Transition (2009) (0)
- DATA CAPTURE VIA MOBILE ELECTRONIC CLINICAL OUTCOME ASSESSMENTS (eCOA): Meeting the New Demands for Patient Reported Outcomes (PRO) (2015) (0)
- The Queensland Trauma Plan Project - preliminary results (2003) (0)
- Validation of a computer touch screen version of the WOMAC 3.1 likert scale osteoarthritis questionnaire (2003) (0)
- Evaluation of the OARSI and OMERACT-OARSI sets of responder criteria in patients treated with hylan G-F 20 for knee osteoarthritis (2003) (0)
- Osteoarthritis and Cartilage. 6th World Congress of the OsteoArthritis Research Society International (2001) (0)
- Reporting, Application and Utilization (1993) (0)
- PAR15 PRELIMINARY INVESTIGATION OF THE DISCRIMINATORY CAPACITY OF MEASURES OF LOW INTENSITY SYMPTOM STATE-ATTAINMENT USING THE WOMAC PAIN SUBSCALE SCORE IN PATIENTS TREATED WITH HYLAN G-F 20 FOR KNEE OSTEOARTHRITIS (2006) (0)
- Degenerative Joint Disease (1985) (0)
- Relationship between enantiomer levels of flurbiprofen and clinical response in rheumatoid arthritis (1991) (0)
- Transition from IJDMR to IJDM (2010) (0)
- Investigation of the Relationship Between Ageing and Different Aspects of Physical Functioning (2013) (0)
- A prospective, randomized controlled trial evaluating the effectiveness and safety of hylan G-F 20 in patients with knee osteoarthritis: six month clinical results of a single course of treatment (2002) (0)
- Rheumatoid arthritis in twins Conclusive In ( Jr Deceased Refused to respond Sick Firm diagnosis Healthy musculoskeletal system (0)
- A randomised trial of the effectiveness, cost effectiveness and cost utility of hylan G-F 20 for osteoarthritis of the knee (2000) (0)
- Clinimetric properties of a new outcome measure: the Hand-Osteoarthritis Aesthetic Damage Index (2012) (0)
- An evaluation of the ICD-10 as an epidemiological tool for rheumatology practice audit (2004) (0)
- Take the measure of osteoarthritis (2008) (0)
- Health economic evaluation of hylan G-F 20 in knee osteoarthritis (2000) (0)
- Road traffic crashes, musculoskeletal injury and the risk factors for osteoarthritis (2007) (0)
- Juvenile Chronic Arthritis (1985) (0)
- Effects of Strontium Ranelate On Knee Osteoarthritis Pain: A Responder Analysis (2012) (0)
- SAT0077 Examinations of the norwegain version of auscan ? a disease specific measure of hand osteoarthritis (oa) (2001) (0)
- CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH SPINAL CANAL STENOSIS AND HYPEREXTENSION INJURIES OF THE CERVICAL SPINE. (2003) (0)
- Clinical measurement in osteoarthritis (2002) (0)
- Digestive Disorders of the Horse. (1937) (0)
- The health related quality of life burden in routine rheumatology practice (2003) (0)
- Hylan G-F 20 for knee osteoarthritis (OA) (2003) (0)
- Clinical Efficacy with Cox-2 Inhibition (2000) (0)
- MEASURING BENEFICIAL AND ADVERSE EVENTS IN (1996) (0)
- PARATRANSIT PROFILE DEVELOPMENT FOR SMALL URBAN CITIES. PHASE I (1984) (0)
- Epidemiology of acute cervical spine injury: a Queensland Trauma Registry 2005-2010 perspective (2012) (0)
- Major Traumatic Injury in Queensland 1998-2001 - what affects survival? (2004) (0)
- Difficulty in ‘Return-to-Work’ After Whiplash Injury: The Role of Pain Self-Efficacy in Mediating the Effects of Neck Disability on Perceived Difficulty in the Return to Work Process (2005) (0)
- SAT0341 Strontium Ranelate Improves Osteoarthritis Symptoms Compared to Placebo in Patients with Knee OA - The Sekoia Study (2013) (0)
- Strontium ranelate increases the number of patients with improvement in osteoarthritis symptoms compared to placebo in the SEKOIA study (2013) (0)
- Comparison of ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel (2002) (0)
- WORKSHOP REPORT - HEALTH-STATUS INSTRUMENTS UTILITIES (1995) (0)
- Viscosupplementation with hylan G-F 20: Evidence for incorporation into osteoarthritis management guidelines (2000) (0)
- Outcome measures in rheumatoid arthritis (2002) (0)
- Health related quality of life and burden of disease in a tertiary rheumatology practice in Australia (2003) (0)
- SAT0076 Patients with osteoarthritis (oa) report more severe pain than age- and gender matched rheumatoid arthritis (ra) patients (2001) (0)
- Evaluating Patient Acceptable Symptomatic State (Pass) in Osteoarthritis (Oa): a Preliminary Comparison of Two Different Acceptability Elicitation Strategies (2015) (0)
- Development of a French short form of the WOMAC function scale based on the patients' and experts' perspective (2003) (0)
- Internet-based indicated prevention for panic disorder: An effectiveness trial in primary care (2005) (0)
- Changing perceptions of osteoarthritis (1996) (0)
- The seronegative spondyloarthropathies. (1990) (0)
- Clinical benchmarking in Knee OA following viscosupplementation with Synvisc-One (2014) (0)
- Examining minimal perceptible clinical improvement criteria in patients treated with hylan G-F-20 for knee osteoarthritis (2004) (0)
- Measuring beneficial and adverse events in osteoarthritis clinical trials (1996) (0)
- Predictors of osteoarthritis(OA) improvement in patients treated with Hylan G-F for knee OA. (2004) (0)
- Health status assessment in clinical research and clinical practice environments in osteoarthritis (2003) (0)
- Class-efficacy of hyaluronan/hylan versus placebo in knee osteoarthritis: A Cochrane Review (2005) (0)
- The effects of post traumatic stress symptomatology on recovery in children with traumatic brain injury: A longitudinal study (2005) (0)
- Outcome measures used in traumatic brain injury and spinal cord lesions in Australia - Can there be a consensus? (2004) (0)
- Strontium ranelate reduces the number of radiological or radioclinical progressors in patients with primary knee osteoarthritis (2012) (0)
- Effectiveness and safety of Hylan G-F 20 compared to steroid injections in patients with knee osteoarthritis (2003) (0)
- Cognitive-linguistic impairment subsequent to mild traumatic brain injury (2006) (0)
- DEVELOPMENT AND APPLICATION OF RESPONDER CRITERIA, STATE-ATTAINMENT CRITERIA AND NORMATIVE VALUES IN OSTEOARTHRITIS (2007) (0)
- Interaction between flurbiprofen and H2-antagonists in rheumatoid arthritis (1991) (0)
- A Cochrane review (update 2004): Hylan G-F 20 vs placebo for knee OA (2004) (0)
- Statistical reappraisal oftheclinical significance of nail beading inrheumatoid arthritis (1985) (0)
- Clinically meaningful effect of strontium ranelate on knee osteoarthritis symptoms (2012) (0)
- A preliminary study of magnetic resonance relaxation times (T1 and T2) in inflammatory and degenerative synovial fluids. (1991) (0)
- Development, validation and globalisation of a health status measure for evaluating patients with osteoarthritis (2005) (0)
- Osteoarthritis of the Hands, Hips and Knees in an Australian Twin Sample — Evidence of Association with the Aggrecan VNTR Polymorphism (2003) (0)
- Antimalarial-induced ocular toxicity during the treatment of rheumatoid arthritis (1987) (0)
- Is maintenance in gold therapy necessary? A double-blind, placebo controlled, gold discontinuation study (2000) (0)
- Similarities and Differences in the Assessment of Function in Osteoporosis (Op) and Osteoarthritis (Oa) (2013) (0)
- Osteoarthritis Modular Measurement System (O2MS): Validity and responsiveness of Module 4 (Patient Global Assessment) (2011) (0)
- Examination in osteoarthritis reliability and standardization of the knee (2002) (0)
- Circadian and circaseptan rhythmicity in pain, stiffness and fatigue in fibromyalgia (2002) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nicholas Bellamy?
Nicholas Bellamy is affiliated with the following schools:
